Prevalence of blindness and visual impairment among Jordanian diabetics

European Journal of Ophthalmology

Volumn 15, Issue 1, 2005, Pages 62-68

  Al Till, Maha I ^a,d   Al Bdour, M D ^b   Ajlouni, K M ^c  

^a JORDAN UNIVERSITY HOSPITAL   (Jordan)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c National Center for Diabetes Endocrinology and Genetics Jordan   (Jordan)

^d NONE   (Jordan)

Author keywords

Blindness; Diabetic retinopathy; Visual impairment

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLINDNESS; CATARACT; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JORDAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO; VISUAL IMPAIRMENT; ADOLESCENT; CATARACT EXTRACTION; CHILD; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT; STATISTICS; VISUAL DISORDER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BLINDNESS; CATARACT; CATARACT EXTRACTION; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; JORDAN; MALE; MIDDLE AGED; PREVALENCE; SEX DISTRIBUTION; VISION DISORDERS; VISUALLY IMPAIRED PERSONS;

EID: 15544383223     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210501500110     Document Type: Article

References (26)

1. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974; 78: 58-67.
2. Evans J. Causes of blindness and partial sight in England and Wales 1990-1991. London: HMSO, 1995.
3. Ajlouni K, Jaddon H, Batieha A. Diabetes and impaired glucose tolerance test in Jordan: prevalence and associated risk factors. J Intern Med. 1998; 244: 317-23.
4. Al-Bdour M, Al-Till M, Abu-khader I. Causes of blindness among adult Jordanians: a hospital-based study. Eur J Ophthalmol 2002; 12: 5-10.
5. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991; 98 (Suppl): S739-834.
6. Heriot WJ, Borger JP, Zimmet P, King H, Taylor R, Raper LR. Diabetic retinopathy in a natural population. Aust J Ophthalmol 1983; 11: 175-9.
7. Nielsen NV. Diabetic retinopathy. The course of retinopathy in diabetics treated with oral hypoglycemic agents and diet regime alone. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol 1984; 62: 266-70.
8. Danielsen R, Jonasson F, Helgason T. Prevalence of retinopathy and proteinuria in type 1 diabetics in Iceland. Acta Med Scand 1982; 212: 277-84.
9. Jerneld B, Algvere P. The prevalence of retinopathy in insulin-dependent juvenile-onset diabetes mellitus. A fluorescein-angiographic study. Acta Ophthalmol 1984; 62: 617-20.
10. Jerneld B, Algvere P. The prevalence of retinopathy in diabetics treated with oral antihyperglycemic agents. Acta Ophthalmol 1985; 63: 535-40.
11. Klein R, Klein BEK, Moss SE, Davies MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520-4.
12. Klein R, Klein BEK, Moss SE, Davies MD, DeMets DL. The Wisconsin Epidemiologie Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527-31.
13. Broadbent DM, Scott JA, Vora JP, Harding SP. Prevalence of diabetic eye disease in an inner city population: the Liverpool diabetic eye study. Eye 1999; 13: 160-5.
14. Abu El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, Kangave D, Moharram OA. Risk factors for diabetic retinopathy among Saudi diabetics. Int Ophthalmol 1999; 22: 155-61.
15. El Haddad OA, Saad MK. Prevalence and risk factors for diabetic retinopathy among Omani diabetics. Br J Ophthalmol 1998; 82: 901-6.
16. Kahn HA, Bradley RF. Prevalence of diabetic retinopathy: age, sex, and duration of diabetes. Br J Ophthalmol 1975; 59: 345-9.
17. Sjolie AK, Stephenson J, Aldington S, et al. Retinopathy and vision loss in insulin dependent diabetes in Europe. The EuroDiab IDDM complications study. Ophthalmology 1997;104:252-60.
18. Khandekar R, Al Lawattii J, Mohammed AJ, Al Raisi A. Diabetic retinopathy in Oman: a hospital based study. Br J Ophthalmol 2003; 87: 1061-4.
19. Janghorbani M, Amini M, Ghanbari H, Safaice H. Incidence of and risk factors for diabetic retinopathy in Isfah Iran. Ophthalmic Epidemiol 2003; 10: 81-95.
20. Hayward LM, Burden ML, Burden AC, et al. What is the prevalence of visual impairment in the general and diabetic populations: are there ethnic and gender differences? Diabet Med 2002; 19: 27-34.
21. Henricsson M, Tyrberg M, Heijl A, Janzon L. Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening program. Acta Ophthalmol 1996; 74: 533-8.
22. Thompson JR, Du L, Rosenthal AL. Recent trends in the registration of blindness and partial sight in Leicestershire. Br J Ophthalmol 1989; 73: 95-9.
23. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent DM. N Engl J Med 1993; 329: 977-86.
24. United Kingdom Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33. Lancet 1998; 352: 837-53.
25. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. ETDRS Report Number 4. Int Ophthalmol Clin 1987; 27: 265-72.
26. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: DRS Report Number 2. Ophthalmology 1978; 58: 82-106.